Manufacturer Supply Weight Loss Peptide GLP-1 Retatrutide BPC 157 Selank

Retatrutide is a new type of multi-target peptide drug , it is a triple receptor agonist of GLP-1R/-GIPR/GCGR, Its core mechanism is to regulate the metabolic process by acti-vating glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropicpolypeptide (GIP) and glucagon (GCG) receptors at the same time, and isused for the treatment of obesity and type 2 diabetes.

• Blood glucose regulation: Activates GIPR, GLP-1R, and GCGR to boost insulin, suppress glucagon, delay gastric emptying, and stabilize blood sugar.

• Weight management: Reduces appetite via GLP-1R and promotes fat breakdown/energy metabolism through GCGR, aiding weight loss.

• Potential cardiovascular benefits: May improve blood lipids, blood pressure, etc., but needs more research.

• Type 2 diabetes: Helps control blood glucose (lowers HbA1c) in adults with poor response to traditional treatments, especially those with obesity.

• Obesity management: Assists weight loss as an adjunct to diet and exercise for BMI ≥30 kg/m² (simple obesity) or BMI ≥27 kg/m² with obesity-related complications.

Important Notice: This product is for research purposes only